Renée Cornelia Gerarda De Bruin

Title: Renée Cornelia Gerarda De Bruin: Innovator in Antibody Research

Introduction

Renée Cornelia Gerarda De Bruin is a prominent inventor based in Amsterdam, Netherlands. She has made significant contributions to the field of biotechnology, particularly in the development of single domain antibodies. With a total of 5 patents to her name, her work has the potential to impact various therapeutic applications.

Latest Patents

One of her latest patents focuses on single domain antibodies targeting CD1d. This invention relates to compounds, specifically polypeptides, that bind to the non-classical MHC protein CD1d and modulate its biological functions. The invention includes compounds and polypeptides that consist of at least one single domain antibody, which specifically binds to CD1d. Additionally, methods and uses employing these compounds, polypeptides, and single-domain antibodies are also provided.

Career Highlights

Throughout her career, Renée has worked with notable companies such as Lava Therapeutics N.V. and Lava Therapeutics B.V. Her innovative research has positioned her as a key figure in the biotechnology sector, contributing to advancements in antibody therapies.

Collaborations

Renée has collaborated with esteemed colleagues, including Johannes Jelle Van Der Vliet and Tanja Denise De Gruijl. These partnerships have further enhanced her research and development efforts in the field.

Conclusion

Renée Cornelia Gerarda De Bruin is a distinguished inventor whose work in single domain antibodies is paving the way for new therapeutic solutions. Her contributions to biotechnology are noteworthy and continue to influence the industry.